To investigate the potential role of DRGs in CRC progression, 10 DRGs (GYS1, NDUFS1, NDUFA11, OXSM, LRPPRC, NUBPL, NCKAP1, RPN1, SLC3A2, and SLC7A11) were obtained from Liu’s study (10). This evidence concerns the gene GYS1 and colorectal carcinoma.